Gabir Layla, Bell Jonathan, Praag Aisha, Rios Margarita, Devlin Stephanie, Khurana Renuka, Taylor Melanie
Maricopa County Department of Public Health, Community Health & Records Services Division, Phoenix AZ.
Sex Transm Dis. 2025 Jul 18. doi: 10.1097/OLQ.0000000000002223.
Arizona has led the nation for rates of congenital syphilis. The purpose of this study was to evaluate compliance with mandated three timepoint syphilis testing for pregnant women attending prenatal care, describe access to benzathine penicillin G (BPG) treatment, and assess receipt and use of Think Syphilis campaign materials in Maricopa County, AZ.
A facility-level cross-sectional survey was performed among prenatal care providers and clinical staff in 2022-2023. Responses from individual participants were applied to their facilities, including respective satellite offices within their corporations.
Responses from 42 distinct healthcare facilities were included, representing 104 outpatient obstetrician-gynecologist (Ob/Gyn) clinical settings. These facilities represented 232 delivering providers accounting for 33,196 live births, approximately 68% of all reported live births in Maricopa County for 2021. 97.6% (41/42) reported use of syphilis screening policies for pregnant women. Reported compliance with performing prenatal syphilis testing was 78.6% (33/42) for syphilis at first prenatal care visit and 73.8% (31/42) during the third trimester. Among providers with first-hand knowledge of hospital-based screening practices, 76.5% (13/17) reported syphilis screening at delivery. Only 11.9% (5/42) reported on-site clinic-based administration of BPG; 71.4% (30/42) reported referring syphilis patients to an external site for treatment with BPG. Barriers to on-site treatment included cost and perception of syphilis as rare. The Maricopa County STI Clinic was the most reported treatment referral site by 90.5% (19/21) of respondents. Regarding the Think Syphilis campaign, 21.4% (9/42) confirmed receipt of campaign materials, and of these 77.8% (7/9) shared materials with office staff.
Reported performance of mandated syphilis testing for pregnant women attending prenatal care in Maricopa County is substantial. However, clinic-based barriers to on-site BPG administration exist. This survey afforded an opportunity to educate providers and clinic staff on maternal syphilis testing and treatment using the Think Syphilis campaign.
亚利桑那州的先天性梅毒发病率在全国居首。本研究的目的是评估为接受产前护理的孕妇进行规定的三个时间点梅毒检测的依从性，描述苄星青霉素G（BPG）治疗的可及性，并评估亚利桑那州马里科帕县梅毒防治宣传活动材料的接收和使用情况。
2022年至2023年期间，对产前护理提供者和临床工作人员进行了机构层面的横断面调查。个体参与者的回答应用于他们所在的机构，包括其公司内各自的卫星办公室。
纳入了42家不同医疗机构的回复，代表104个门诊妇产科临床机构。这些机构有232名接生人员，共接生33196例活产，约占2021年马里科帕县所有报告活产的68%。97.6%（41/42）的机构报告对孕妇采用了梅毒筛查政策。报告的首次产前护理就诊时梅毒检测的依从率为78.6%（33/42），孕晚期为73.8%（31/42）。在了解医院筛查做法的提供者中，76.5%（13/17）报告在分娩时进行梅毒筛查。只有11.9%（5/42）的机构报告在诊所现场给予BPG治疗；71.4%（30/42）的机构报告将梅毒患者转至外部机构接受BPG治疗。现场治疗的障碍包括成本以及认为梅毒罕见。90.5%（19/21）的受访者报告马里科帕县性传播感染诊所是最常被提及的治疗转诊机构。关于梅毒防治宣传活动，21.4%（9/42）的机构确认收到了宣传材料，其中77.8%（7/9）与办公室工作人员分享了这些材料。
报告显示，马里科帕县为接受产前护理的孕妇进行规定梅毒检测的执行情况良好。然而，诊所现场给予BPG治疗存在障碍。本次调查为利用梅毒防治宣传活动对提供者和诊所工作人员进行孕产妇梅毒检测和治疗教育提供了契机。
